These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 12706704

  • 1. Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study.
    Gorse GJ, O'Connor TZ, Young SL, Mendelman PM, Bradley SF, Nichol KL, Strickland JH, Paulson DM, Rice KL, Foster RA, Fulambarker AM, Shigeoka JW, Kuschner WG, Goodman RP, Neuzil KM, Wittes J, Boardman KD, Peduzzi PN.
    Vaccine; 2003 May 16; 21(17-18):2133-44. PubMed ID: 12706704
    [Abstract] [Full Text] [Related]

  • 2. Immunity to influenza in older adults with chronic obstructive pulmonary disease.
    Gorse GJ, O'Connor TZ, Newman FK, Mandava MD, Mendelman PM, Wittes J, Peduzzi PN.
    J Infect Dis; 2004 Jul 01; 190(1):11-9. PubMed ID: 15195238
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct 01; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 4. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD, CAIV-T Study Group.
    Pediatr Infect Dis J; 2006 Oct 01; 25(10):870-9. PubMed ID: 17006279
    [Abstract] [Full Text] [Related]

  • 5. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
    Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF.
    Ann Intern Med; 1992 Oct 15; 117(8):625-33. PubMed ID: 1530193
    [Abstract] [Full Text] [Related]

  • 6. Influenza virus vaccination of patients with chronic lung disease.
    Gorse GJ, Otto EE, Daughaday CC, Newman FK, Eickhoff CS, Powers DC, Lusk RH.
    Chest; 1997 Nov 05; 112(5):1221-33. PubMed ID: 9367461
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.
    Treanor JJ, Kotloff K, Betts RF, Belshe R, Newman F, Iacuzio D, Wittes J, Bryant M.
    Vaccine; 1999 Dec 10; 18(9-10):899-906. PubMed ID: 10580204
    [Abstract] [Full Text] [Related]

  • 8. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.
    Pediatrics; 2007 Sep 10; 120(3):e553-64. PubMed ID: 17698577
    [Abstract] [Full Text] [Related]

  • 9. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination.
    Gorse GJ, O'connor TZ, Young SL, Habib MP, Wittes J, Neuzil KM, Nichol KL.
    Chest; 2006 Oct 10; 130(4):1109-16. PubMed ID: 17035445
    [Abstract] [Full Text] [Related]

  • 10. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003 Oct 10; 4(5):312-9. PubMed ID: 12952502
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
    Halloran ME, Piedra PA, Longini IM, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP.
    Vaccine; 2007 May 16; 25(20):4038-45. PubMed ID: 17395338
    [Abstract] [Full Text] [Related]

  • 12. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
    Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF.
    J Infect Dis; 1994 Jan 16; 169(1):68-76. PubMed ID: 8277200
    [Abstract] [Full Text] [Related]

  • 13. Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults.
    Gorse GJ, Belshe RB, Munn NJ.
    Chest; 1991 Oct 16; 100(4):977-84. PubMed ID: 1914615
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent.
    Belshe RB, Mendelman PM.
    Immunol Allergy Clin North Am; 2003 Nov 16; 23(4):745-67. PubMed ID: 14753390
    [Abstract] [Full Text] [Related]

  • 15. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA, Cate TR, Nino D, Huggins LL, Six HR, Quarles JM, Couch RB.
    J Infect Dis; 2001 Jan 15; 183(2):329-332. PubMed ID: 11110645
    [Abstract] [Full Text] [Related]

  • 16. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB, Gruber WC.
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec 29; 356(1416):1947-51. PubMed ID: 11779396
    [Abstract] [Full Text] [Related]

  • 17. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T, Kirstein J, Devota Go G, Leav B, Ruzycky ME, Isakov L, de Bruijn M, Oberye J, Heijnen E.
    Lancet Respir Med; 2018 May 29; 6(5):345-356. PubMed ID: 29631857
    [Abstract] [Full Text] [Related]

  • 18. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
    Beyer WE, Palache AM, de Jong JC, Osterhaus AD.
    Vaccine; 2002 Jan 31; 20(9-10):1340-53. PubMed ID: 11818152
    [Abstract] [Full Text] [Related]

  • 19. [Live attenuated and inactivated influenza vaccines: data from direct comparative studies].
    Kashirina OS, Vasil'ev IuM.
    Zh Mikrobiol Epidemiol Immunobiol; 2014 Jan 31; (1):103-19. PubMed ID: 24738303
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.
    N Engl J Med; 1998 May 14; 338(20):1405-12. PubMed ID: 9580647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.